[HTML][HTML] Hyperoside attenuates bleomycin-induced pulmonary fibrosis development in mice
J Huang, X Tong, L Zhang, Y Zhang, L Wang… - Frontiers in …, 2020 - frontiersin.org
Idiopathic pulmonary fibrosis (IPF) is a progressive, lethal, and chronic lung disease. There
are no effective drug therapies for IPF. Hyperoside, a flavonoid glycoside, has been proven …
are no effective drug therapies for IPF. Hyperoside, a flavonoid glycoside, has been proven …
Hyperoside Attenuates Bleomycin-Induced Pulmonary Fibrosis Development in Mice
J Huang, X Tong, L Zhang, Y Zhang… - Frontiers in …, 2020 - pubmed.ncbi.nlm.nih.gov
Idiopathic pulmonary fibrosis (IPF) is a progressive, lethal, and chronic lung disease. There
are no effective drug therapies for IPF. Hyperoside, a flavonoid glycoside, has been proven …
are no effective drug therapies for IPF. Hyperoside, a flavonoid glycoside, has been proven …
Hyperoside attenuates bleomycin-induced pulmonary fibrosis development in mice.
J Huang, X Tong, L Zhang, Y Zhang, L Wang, D Wang… - 2020 - cabidigitallibrary.org
Idiopathic pulmonary fibrosis (IPF) is a progressive, lethal, and chronic lung disease. There
are no effective drug therapies for IPF. Hyperoside, a flavonoid glycoside, has been proven …
are no effective drug therapies for IPF. Hyperoside, a flavonoid glycoside, has been proven …
Hyperoside Attenuates Bleomycin-Induced Pulmonary Fibrosis Development in Mice.
J Huang, X Tong, L Zhang, Y Zhang… - Frontiers in …, 2020 - europepmc.org
Idiopathic pulmonary fibrosis (IPF) is a progressive, lethal, and chronic lung disease. There
are no effective drug therapies for IPF. Hyperoside, a flavonoid glycoside, has been proven …
are no effective drug therapies for IPF. Hyperoside, a flavonoid glycoside, has been proven …
[HTML][HTML] Hyperoside Attenuates Bleomycin-Induced Pulmonary Fibrosis Development in Mice
J Huang, X Tong, L Zhang, Y Zhang… - Frontiers in …, 2020 - ncbi.nlm.nih.gov
Idiopathic pulmonary fibrosis (IPF) is a progressive, lethal, and chronic lung disease. There
are no effective drug therapies for IPF. Hyperoside, a flavonoid glycoside, has been proven …
are no effective drug therapies for IPF. Hyperoside, a flavonoid glycoside, has been proven …
[引用][C] Hyperoside Attenuates Bleomycin-Induced Pulmonary Fibrosis Development in Mice
J Huang, X Tong, L Zhang, Y Zhang… - Frontiers in …, 2020 - jglobal.jst.go.jp
Agraval H. Yadav UCS (2019). MMP-2 and MMP-9 mediate cigarette smoke extract-induced
epithelial-mesenchymal transition in airway epithelial cells via EGFR/Akt/GSK3β/β-catenin …
epithelial-mesenchymal transition in airway epithelial cells via EGFR/Akt/GSK3β/β-catenin …
Hyperoside Attenuates Bleomycin-Induced Pulmonary Fibrosis Development in Mice.
J Huang, X Tong, L Zhang, Y Zhang… - Frontiers in …, 2020 - europepmc.org
Idiopathic pulmonary fibrosis (IPF) is a progressive, lethal, and chronic lung disease. There
are no effective drug therapies for IPF. Hyperoside, a flavonoid glycoside, has been proven …
are no effective drug therapies for IPF. Hyperoside, a flavonoid glycoside, has been proven …